Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
about
Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorderQuality of life in patients with esophageal stenting for the palliation of malignant dysphagia.High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis.The cost effectiveness of radiofrequency ablation for Barrett's esophagus.Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal studyEndoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instabilityStatins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis.Postoperative complications do not affect long-term outcome in esophageal cancer patients.Adjuvant Statin Therapy for Esophageal Adenocarcinoma: A Cost-Utility Analysis.Preferences and utilities for health states after treatment for oropharyngeal cancer: transoral robotic surgery versus definitive (chemo)radiotherapy.Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia.
P2860
Q24802062-B92380C0-D7F0-43F4-B56C-A9293C3E3D27Q33796599-CD0AF737-9DC9-4F37-B8E8-854915157D99Q35594205-74EA7DB6-9F62-41B6-A894-85784568B2E4Q36195501-6C3FBA29-E0D1-4AFE-A02E-3C5C93FB7187Q36376650-D935DA48-5DFE-4D2A-8B04-AF55C9CA5F03Q36921955-0C635E59-7C3A-4767-903B-E0D5EE1B47C3Q37633568-76B5820E-F64F-446F-B3F2-2E6122955735Q43004712-4A1F135C-1BF0-448B-AC00-93BFCAA6C5D1Q44713290-2885B2E1-D348-4847-B663-296FB0356E38Q47360791-1F32415D-E05F-46A3-BD00-F453259A1DF9Q48259007-D17D6C53-CD85-4C15-9A39-5F142CE9D068Q48435798-569FCA01-5712-4B00-93DB-B2E7BCBB9F66
P2860
Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Transhiatal vs extended transt ...... ties and treatment preferences
@ast
Transhiatal vs extended transt ...... ties and treatment preferences
@en
type
label
Transhiatal vs extended transt ...... ties and treatment preferences
@ast
Transhiatal vs extended transt ...... ties and treatment preferences
@en
prefLabel
Transhiatal vs extended transt ...... ties and treatment preferences
@ast
Transhiatal vs extended transt ...... ties and treatment preferences
@en
P2093
P2860
P356
P1476
Transhiatal vs extended transt ...... ties and treatment preferences
@en
P2093
A G E M de Boer
J B F Hulscher
J C J M de Haes
J J B van Lanschot
J W van Sandick
M A G Sprangers
P F M Stalmeier
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600203
P407
P577
2002-03-01T00:00:00Z